The repeated combination of TMZ chemotherapy and local application of MGMT modified γδ T cells over several months against small, undetectable malignant cell clusters should both reduce NKG2DL shedding, improve vulnerability to lysis by γδ T cells and inhibit formation of a vascularized and immunosuppressive tumor mass (62). The gene discussed is MGMT; the disease is neoplasm.